USFDA Approved Latest Drug for Lung Cancer Patients
Beacon Pharmaceuticals Limited, the leading oncology company in Bangladesh, has introduced a groundbreaking treatment for lung cancer: Tagrix, the first global generic version of osimertinib.
Learn more
Create positive change at Beacon
At Beacon Pharmaceuticals PLC, we are dedicated to fostering positive change in the pharmaceutical industry. Our commitment extends to innovating healthcare solutions, promoting sustainability, and contributing to community well-being. Through ethical practices and a focus on continuous improvement, we aim to make a lasting impact on industry and society at large.
Be a part of Beacon team
Becoming part of the Beacon team means joining a dynamic and purposeful community. With a focus on innovation, global impact, and personal growth, the Beacon team offers an inspiring environment to contribute, learn, and excel.
